AMINOSYN II 10% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
NDAINJECTIONINJECTABLE
Approved
Apr 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN II 10% W/ ELECTROLYTES is a parenteral amino acid solution with balanced electrolytes (magnesium, potassium, sodium, phosphate) designed for intravenous nutrition support. It provides essential amino acids and minerals for patients unable to consume food orally, supporting protein synthesis and metabolic function. This is a foundational nutritional therapy rather than a disease-targeted drug.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating a mature, stable franchise with likely smaller, defensive team focus.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN II offers stability in a mature, institutional-focused product with predictable revenue streams, but limited growth or innovation upside. Career advancement typically moves toward larger institutional portfolios, supply chain optimization, or transition to growth-stage products.
Hospital Account ManagerField Sales Representative (Institutional)
Worked on AMINOSYN II 10% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.